Page 911 - Cardiac Nursing

/
0
0
9
9
/
/
2
2
6
6
/
9
88.
88.
88.
6-8
6-8
6-8
d
2
2
qx
qx
d
e 8
87
87
g
g
e 8
ar
a
a
Apt
Apt
ar
Pa
1
1
0:0
009
009
009
M
M
Pa
0:0
1 P
1 P
K34
0-c
K34
K34
0-c
p87
p87
39_
39_
LWB
LWBK340-c39_p876-888.qxd 29/06/2009 10:01 PM Page 887 Aptara
LWB
C HAPTER 39 / Diabetes Mellitus and Metabolic Syndrome 887
providers, through advocacy, education, and one-to-one personal 24. Lorenzo, C., Williams, K., Hunt, J., et al. (2007). The National Choles-
care and connection to people with diabetes and their families, will terol Education Program-Adult Treatment Panel III, International Dia-
help to slow the pace of this global epidemic, one person at a time. betes Federation, and World Health Organization Definitions of the
Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and
0
0
Diabetes. Diabetes Care, 30, 8–13.
25. Zimmet, P. Z., George, K., Alberti, M., et al. (2005). Mainstreaming the
REFERENCES metabolic syndrome: A definitive definition. The Medical Journal of
Australia, 184(4), 175–176. Retrieved December 16, 2007, from http://
4
4
1. International Diabetes Federation (IDF). (2007). Diabetes alas. Belgium: www.mja.com.au/public/issues/183_04_150805?zim10442_fm.html
International Diabetes Federation. 26. Reaven, G. M. (1988). Banting lecture. Role of insulin resistance in hu-
7
7
2. World Health Organization. (2004). Diabetes Action Now: An initiative of man disease. Diabetes 37, 1595–1607.
the World Health Organization and International Diabetes Foundation. 27. Kahn, R., Buse, J., Ferrannino, E., et al. (2005). The Metabolic syndrome:
Geneva: Switzerland. Time for a critical appraisal. Diabetes Care, 28(9), 2289–2304.
3. United Nations General Assembly Resolution 61/225. World Diabetes 28. WHO Consultation. (1999). Definition, diagnosis and classification of dia-
Day 18 January 2007. betes mellitus and its complications. Geneva, World Health Organization.
4. World Health Organization. (2006). Definition and diagnosis of diabetes Report 99.2.
mellitus and intermediate hyperglycemia: Report of a World Health Organi- 29. National Cholesterol Education Program (NCEP). (2001). Executive
zation and International Diabetes Federation. Geneva, Switzerland. summary of the third report of the National Cholesterol Education Pro-
5. Lars Ryde’n, L., Standl, E., Bartnik, M., et al. (2007). Guidelines on dia- gram Expert Panel on detection, evaluation, and treatment of high blood
betes, pre-diabetes, and cardiovascular disease: The Task Force on Diabetes cholesterol in adults. JAMA, 285, 2486–2497.
and Cardiovascular Disease of the European Society of Cardiology (ESC) 30. Alberti, K. G., Zimmet P., & Shaw, J. (2005). The metabolic syndrome—
6
6
and the European Association for the Study of Diabetes (EASD). Euro- A new world definition. The Lancet, 366, 1059–1062.
pean Heart Journal, 28, 88–136. 31. American Association of Clinical Endocrinologists. (2003). ACE position
6. American Diabetes Association. (2008). Clinical practice recommenda- statement on the insulin resistance syndrome. Endocrine Practice, 9(3),
tions: Diagnosis and classification of diabetes mellitus. Diabetes Care, 240–252.
31(Suppl. 1), S12–S54. 32. American Diabetes Association Website. http://www.diabetes.org/
7. Wild, S., Roglic, G., Green, A., et al. (2004). Global prevalence of diabetes diabetesphd
e
estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 33. Eriksson, K. F., & Lindgarde, F. (1991). Prevention of type 2 diabetes mel-
e
1047–1053. litus by diet and physical exercise. The 6 year Malmo feasibility study. Dia-
0
0
8. The Indian Task Force on Diabetes Care in India. Accessed January 31, betologia, 20, 891–898.
2008 from http://diabetesindia.com/diabetes/itfdci.htm 34. Pan, X. R., Li, G. W., Hu, Y. H., et al. (1997). Effects of diet and exercise
9. National Institute of Diabetes and Digestive and Kidney Diseases. (2005). in preventing NIDDM in people with impaired glucose tolerance. Diabetes
0
0
National Diabetes Statistics fact sheet: General information and national es- Care, 20, 537–544.
timates on diabetes in the United States. Bethesda, MD: U.S. Department 35. Tuomilehto, J., Lindstrom, J., Eriksson J. G., et al. (2001). Prevention of
of Health and Human Services, National Institute of Health. type 2 diabetes mellitus by changes in lifestyle among subjects with im-
4
4
10. Eppens, M., Craig, M., Cusumano, J., et al. (2006). Prevalence of diabetes paired glucose tolerance. New England Journal of Medicine, 344,
complications in adolescents with type 2 compared with type 1 diabetes. 1343–1350.
9
9
Diabetes Care, 29, 1300–1306. 36. Chiasson, J. L., Josse, R. G., Gomis, R., et al. (2002). Acarbose for pre-
11. American Diabetes Association. (2008). Clinical practice recommenda- vention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial.
9
9
e
tions: Standards of medical care. Diabetes Care, 31. (Suppl.1), S14. The Lancet, 359, 2072–2077.
e
12. American Diabetes Association. (2008). Economic costs of diabetes in the 37. Gerstein, H. C., Yusuf, S., Bosch, J., on behalf of the DREAM trial inves-
United States in 2007. Diabetes Care, 31, 1–20. tigators (2006). Effect of rosiglitazone on the frequency of diabetes in pa-
13. American Association of Diabetes Educators. (2006). Art and science of di- tients with impaired glucose tolerance or impaired fasting glucose: A ran-
8
abetes self-management education: A desk reference for health care professionals. domised controlled trial. The Lancet, 368, 1096–1105.
Chicago, Illinois. 38. Buchanan, T. A., Xiang, A. H., & Peters, R. K. (2002). Preservation of
14. Carroll, M. F., & Schade, D. S. (2005). The dawn phenomenon revisited: pancreatic B-cell function and prevention of type 2 diabetes by pharma-
Implications for diabetes therapy. Endocrine Practice, 11(1), 55–64. cological treatment of insulin resistance in high-risk Hispanic women.
15. American Association of Clinical Endocrinologists. (2007). Medical Diabetes, 51, 2769–2803.
guidelines for clinical practice for the management of diabetes mellitus. 39. National Cholesterol Education Program (NCEP). (2002). Third
Endocrine Practice, 13. Report of the National Cholesterol Education Program (NCEP) Expert
16. Knowler, W. C., Barret-Connor E., Fowler, S. E., et al. (2002). Reduction Panel on Detection, Evaluation, and Treatment of High Blood Choles-
6
6
in the incidence of type 2 diabetes with lifestyle intervention or met- terol in Adults (Adult Treatment Panel III). Circulation, 106,
6
6
formin. New England Journal of Medicine, 346, 393–403. 3143–3421.
17. Gale, E. A., Bingley, P. J., & Emmett, C. L. (2004). European Nicoti- 40. American Association of Clinical Endocrinologists. (2007). State of dia-
namide Diabetes Intervention Trial (ENDIT): A randomised controlled betes Complications in America. A Comprehensive Report Issued by the
trial of intervention before the onset of type 1 diabetes. Lancet, 363 American Association of Clinical Endocrinology.
(9413), 925–931. 41. Bypass Angioplasty Revascularization Investigation (BARI) 2 Diabetes: A
18. Rabi, D., Edwards, A., Southern, D., et al. (2006). Association of socio- clinical study. On the internet at www.bari2D.org. University of Pittsburgh,
economic status with diabetes prevalence and utilization of diabetes care Epidemiology data center 2006. Accessed January 21, 2008.
6
6
services. BMC Health Service Research, 6, 124. Retrieved January 22, 2008, 42. Childs, B. P., Cypress, M., & Spollett, G. (2005). Complete nurse’s guide to
from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid 1618393 diabetes care. Virginia: American Diabetes Association (Nurses guide).
19. Fowler, M. (2007). Classification of diabetes: Not all hyperglycemia is the 43. Young-Hyman, D. (2004). Psychosocial factors affecting adherence,
5
5
same. Clinical Diabetes, 25, 74–76. quality of life, and well-being: Helping patients cope. In Medical man-
20. Fowler, M. (2007). Diabetes magnitude and mechanisms. Clincal Dia- agement of type 1 diabetes (162–182). Alexandria, VA: American Diabetes
5
5
betes, 25, 25–28. Association.
E
E
21. UK Prospective Diabetes Study Group (UKPDS). (1998). Effect of inten- 44. Know your ABCs of diabetes—NCBDE. http://ndep.nih.gov/diabetes/
sive blood-glucose control with metformin on complications in over- control/control.htm
2
weight patients with type 2 diabetes. The Lancet, 352, 854–865. 45. The Diabetes Control and Complications Trial (DCCT) Research Group.
2
22. Inzucchi, S. E., Reed, J. W., Fagan, T. F., et al. (2006). Achievement of (1993). The effect of intensive treatment of diabetes on the development
ADA Guidelines among U.S. adults with diabetes: NHANES. Clinical and progression of long-term complications in insulin-dependent diabetes
Insights in Diabetes, 9(3), 1–4. mellitus. New England Journal of Medicine, 329, 977–986.
23. Hinnen, D., Nielsen, L., Waninger, A., et al. (2006). Incretin mimetics and 46. Ohkubo, Y., Kishikawa, H., Araki, E., et al. (1995). Intensive insulin ther-
DPP-IV inhibitors: New paradigms for the treatment or type 2 diabetes. apy prevents the progression of diabetic microvascular complications in
9
9
The Journal of the American Board of Family Medicine, 19(6), 612–620. Japanese patients with non-insulin-dependent diabetes mellitus: A ran-